Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis

NCT01681940 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha-Mannosidosis

Interventions

DRUG: Lamazym

Sponsor

Zymenex A/S

Collaborators

[object Object]